TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma ...

Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-9 study of TECVAYLI® ...
Psychology Today

Why Does Math Make So Many of Us Anxious?

Math anxiety grows from stress, culture, and experience, not ability. By changing how we teach, test, and talk about math, we ...